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Mucinous tubular and spindle renal cell carcinoma (MTSRCC) is a subtype of RCC, which has a polymorphous histology and spindled epithelial cell 
as an inherent carcinomatous component. The tumor has been 
recognized as a distinct entity by the World Health Organization 
tumor classification of 2004 [1]. To date, <100 cases of these 
tumors have been reported in the literature [2]. Sarcomatoid 
change in RCC has an overall incidence of 8% and is well 
documented to occur in the more common subtype of RCC. 
Although MTSRCC by itself does not have aggressive behavior, 
there have been reporting cases of MTSRCC with sarcomatoid 
change having aggressive behavior in the literature search [3].
We present the case of a 45-year-old woman with incidentally 
detected left renal mass, and later on, histopathology revealed 
it to be a mucinous tubular and spindle cell carcinoma with 
sarcomatoid change.
CASE REPORT
A 45-year-old woman presented to our department with a chief 
complaint of incidentally detected left renal mass. She was a 
housewife by occupation, and there were no other complaints of 
hematuria, flank pain, or weight loss. There was no history of fever, 
hypertension, tuberculosis, and diabetes. On physical examination, it 
revealed the presence of a mass occupying the left lumbar region and 
moving with respiration. It was bimanually palpable and ballotable.
All the hematological investigations including renal function 
tests were normal. Chest x-ray was noncontributory. On 
ultrasonography (USG), there was a fairly defined mixed echogenic 
space occupying lesion (SOL), 64×43 mm in the lower aspect 
of the left kidney. There was another well-defined hyperechoic 
SOL, about 25×23 mm in diameter in the upper pole of the left 
kidney, probably an angiomyolipoma (AML). On computerized 
tomography (CT) scan, there was a large heterogeneously 
enhancing soft tissue mass of size 45 mm×69 mm×46 mm 
(enhancement from 39 to 50 H.U.) seen involving lower part of 
the left kidney. The left renal vein was free from any thrombus. 
Fascial planes were intact. There was also a mixed density SOL 
in the upper pole of the left kidney having fat and soft tissue 
component probably an AML (Fig. 1). Left radical nephrectomy 
was performed with an uneventful recovery.
On gross pathologic examination, there was tumor of 
5.5 cm×3.5 cm×2.5 cm, involving lower pole of the left kidney 
with variegated cut surface (Fig. 2). The macroscopic extension 
was limited to the renal parenchyma. Histological features of 
tumor composed of tubules and cords formed by cuboidal cells 
with hyperchromatic nuclei, separated by bubbly myxoid stroma, 
along with an abrupt change into spindle cell morphology 
(Fig. 3). The spindle cell component was composed of fascicles of 
highly pleomorphic malignant cells with hyperchromatic nucleus 
and prominent nucleoli (Fig. 4), with brisk mitotic activity. At 
some areas, a collection of foamy histiocytes and inflammatory 
cells including plasma cells were noted. Histologic type was 
confirmed to be as mucinous tubular and spindle cell carcinoma 
of the kidney with sarcomatoid change. All the margins were 
uninvolved including Gerota’s fascia, and lymphovascular 
invasion was absent. Immunohistochemistry (IHC) was done 
which showed that vimentin was focally positive in tumor cells. 
The epithelial membrane antigen (EMA), alpha-methylacyl-
coenzyme A racemase (AMACR), and cytokeratin 7 (CK7) were 
also positive (Figs. 5 and 6) in tumor cells. At present, she is in 
regular follow-up and doing well for 6 months after surgery.
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DISCUSSION
MTSRCC of the kidney is a rare entity. It was first described in 
1998 and previously classified in the category “RCC, unclassified” 
by He et al. [4]. The issue of the origin of MTSRCC is still 
unsettled. Expression of epithelial markers, namely AMACR, 
EMA, CK7, and vimentin, has been reported in 80–100% of the 
cases, thus supporting a possible origin from distal convoluted 
epithelial cells as in the present case [5].
The tumor is more prevalent among adults with a mean age 
of 53 years (range: 17–82), with a marked female preponderance 
(1:4), not seen to be associated with nephrolithiasis. Clinically, 
Figure 1: Contrast-enhanced computed tomography showing 
angiomyolipoma and heterogeneously enhancing mass in the left 
kidney
Figure 2: A picture of gross specimen
Figure 3: Tumor showing sarcomatoid changes 40× magnification
Figure 4: Tumor having spindle cells with hyperchromatic nucleus 
and prominent nucleoli (40× magnification)
Figure 5: Alpha-methylacyl-coenzyme a racemase positive in tumor 
cells (40× magnification)
Figure 6: Cytokeratin 7 positive in tumor cells (10× magnification)
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they are generally asymptomatic or present with flank pain or 
hematuria and are detected on USG. The age, sex, and clinical 
presentation of the present case were similar to that described in 
the literature [6].
The CT features of MTSRCC are attenuation values ranging 
from 31 to 40 HU on an unenhanced scan and attenuation values 
ranging from 38 to 50 HU on corticomedullary phase which was 
very much similar in our case [3].
There is no consensus regarding the treatment of mucinous 
tubular and spindle cell carcinoma of the kidney with sarcomatoid 
change. It is recommended that although an innocent outcome is 
likely, a close follow-up is warranted. We followed up this patient 
with 3 monthly visits with physical examination, laboratory tests, 
abdominal USG, and a chest X-ray. With regard to the therapy 
of MTSRCC, patients with localized disease are usually treated 
with resection, either partial or radical nephrectomy, and in our 
case, partial nephrectomy was not done as the tumor was more 
than 4 cm in size. For metastatic diseases, there are no reports of 
systemic treatment guideline published to date.
With regard to MTSRCC, where spindle cells dominate, the 
most critical differential diagnosis is sarcomatoid RCC, which can 
develop in any form of RCC, and usually confers an aggressive 
behavior. Basal-appearing spindle cells are an inherent defining 
component of mucinous tubular and spindle cell carcinoma. The 
presence of these benign-appearing spindle cells does not give a 
bad prognosis to this carcinoma. Sarcomatoid change in RCC has 
a worse prognosis and is defined histologically by the presence 
of spindle cells with nuclear pleomorphism and prominent 
nucleoli [7]. These cytologic features were observed in our case, 
but the tumor was not aggressive.
Simon et al. [8] found that, in case of sarcomatoid change, the 
tumor is negative for CK7 and EMA. Furthermore, Dhillon et al. [9] 
found high MIB1 labeling index and negativity for CK7 and 
AMACR in cases with sarcomatoid change, showing aggressive 
behavior. In our case, CK7, AMACR, and EMA were positive. 
Kuroda et al. performed comparative genomic hybridization 
analysis of a case of the high-grade MTSCC that showed a gain 
of chromosomes 1q, 7, 16, 19q, and Y and loss of chromosomes 
1p, 6p, 8p, 11q (del (11) (q23)), and 13. Subsequent G-band 
karyotyping of the same case showed a gain of chromosomes 2, 5, 
7, 12, 16, and 20 and loss of chromosome 15 [10]. Cossu-Rocca 
et al. reported that MTSCC lacks the gain of chromosomes 7 and 
17 and loss of chromosome Y as seen in papillary RCC [11].
CONCLUSION
MTSRCC is a rare entity and its association with sarcomatoid 
change is a rare possibility. Sarcomatoid change is generally 
associated with aggressive behavior but is not always necessary. 
Diagnosis requires histopathology, IHC, and cytogenetics. Close 
follow-up of the entity is essential until a better understanding of 
the biology of this rare tumor is obtained.
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